SCHEMBL24255641

SCHEMBL24255641

c1ccc(-c2nc(-c3ccc(-c4cccc5oc6cc(N(c7ccccc7)c7ccccc7)ccc6c45)cc3)nc(-c3cccc4ccccc34)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 5/20 0.38
MAPT P10636 5/20 0.38
HSD17B10 Q99714 4/20 0.38
HPGD P15428 3/20 0.38
ATM Q13315 2/20 0.38
MAPK1 P28482 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
RAB9A P51151 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26420606 0.98 ALDH1A1 (0.38) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL25852800 0.96 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL25852677 0.95 ALDH1A1 (0.39) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL26421011 0.94 ALDH1A1 (0.36) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL26420452 0.94 ALDH1A1 (0.37) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL26416682 0.92 MAPT (0.33) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL24255692 0.92 ALDH1A1 (0.38) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL26778865 0.91 KDM4E (0.34) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL26420566 0.91 GPR55 (0.32) ALDH1A1KDM4EMAPTHSD17B10HPGD
SCHEMBL26420605 0.91 MAPT (0.35) ALDH1A1KDM4EMAPTHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337529-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2023-10-19 US disclosed
US-20230337529-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2023-10-19 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
EP-4206198-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-07-05 EP disclosed
WO-2022035097-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER 엘티소재주식회사 2022-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 ALDH1A1 544/4885KDM4E 2882/4885MAPT 340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.